Oncogenic <i>KrasG12D</i> Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice

Lena Oßwald(University of Freiburg), Robert Zeiser(University of Freiburg)
Molecular Cancer Research
June 4, 2021
10.1158/1541-7786.mcr-20-0275
Cited by 12

Related Papers

Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
|Blood|2007|393
Immune modulatory effects of oncogenic KRAS in cancer
|Nature Communications|2020|373
The Nlrp3 inflammasome regulates acute graft-versus-host disease
|The Journal of Experimental Medicine|2013|233
Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression
|Oncotarget|2017|65